1) Seino Y, Rasmussen MF, Nishida T, Kaku K. Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes. Current Medical Research & Opinion 26: 1013-1022, 2010.
2) Hongo M: Review article: Barrett's oesophagus and carcinoma in Japan. Alimentary pharmacology & therapeutics 20 (Suppl 8) 50-54, 2004.